Clinical review report: Cladribine (Mavenclad) (EMD serono)
The objective of this report is to perform a systematic review of the beneficial and harmful effects of cladribine for the treatment of relapsing-remitting multiple sclerosis
| Corporate Author: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
2018, October 2018
|
| Edition: | Version: Final with Redactions |
| Series: | CADTH common drug review
|
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | The objective of this report is to perform a systematic review of the beneficial and harmful effects of cladribine for the treatment of relapsing-remitting multiple sclerosis |
|---|---|
| Physical Description: | 1 PDF file (76 pages) illustrations |